Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.
…
continue reading
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
…
continue reading
NEJM AI Grand Rounds, hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine. You’ll learn how AI will change clinical practice and healthcare, how it will impact the patient experience, and about the people who are pushing for innovation. Whether you are an AI researcher or a practicing clinician, these conversations w ...
…
continue reading
This podcast from NEJM Catalyst features interviews with leaders in health care as they discuss innovative ideas and actionable solutions for enhancing the value of health care delivery, providing perspectives on what's working in the industry, what's not, and why.
…
continue reading
Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
…
continue reading
The House reflects medicine’s most pressing issues through the eyes of residents, providing a forum to share their stories from the bedside, where they are learning far more than the lessons of clinical medicine.
…
continue reading
This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.
…
continue reading
A Day in the Life is a podcast for medical students, by medical students. Interviews with attendings about daily life and training may help you explore a range of specialties.
…
continue reading
General Medicine Podcast which keeps you up to date with the latest and greatest medical literature.
…
continue reading
Core IM Podcast
…
continue reading
The Critical Care Commute Podcast is grateful for your ears, insights and feedback. In return its hosts- Peter Brindley and Leon Byker, two ICU doctors in Alberta, Canada- offer up knowledge and debate with some of the most qualified, interesting, enlightened and provocative folks in Critical Care Medicine, and beyond. We strive to keep it practical and concise. Like you, our overriding goal is to get better, do better and feel better.
…
continue reading
Core Internal Medicine via following series: 5 Pearls || Clinically relevant pearls Mind the Gap || Why do we do what we do? Gray Matters || Management Reasoning Hoofbeats || Dissecting clinical reasoning At the Bedside || Explore everyday challenges
…
continue reading
A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
Two critical care guys walk into a recording studio and breakdown intensive care trials both old and new! We'll also do deep dives on specific topics important to practicing intensive care medicine and have special guests talking about their area of expertise! This podcast is made for educational purposes. The content provided in this podcast, and in any linked materials, is not intended and should not be construed as medical advice and should not be used to diagnose or treat any medical con ...
…
continue reading
MedPod Today is a podcast from MedPage Today where leading healthcare professionals and our seasoned reporters discuss the latest news and trends in the medical world. The podcast will feature diverse content, from our poignant medical story-telling show, Anamnesis, to reporter roundtables where our writers dive deeper into some of our most compelling healthcare stories. The podcast will also spotlight clinician conversations with our Editor-In-Chief, Jeremy Faust, MD.
…
continue reading
my life, my struggle
…
continue reading
Doctors and other health care professionals are too often socialized and pressured to become “efficient task completers” rather than healers, which leads to unengaged and unimaginative medical practice, burnout, and diminished quality of care. It doesn’t have to be that way. With a range of thoughtful guests, co-hosts Saul Weiner MD and Stefan Kertesz MD MS, interrogate the culture and context in which clinicians are trained and practice for their implications for patient care and clinician ...
…
continue reading
Welcome to the The med files podcast. I’ll be discussing various topics of medicine. It’s gonna be fun.
…
continue reading
Let's talk about contemporary issues in cardiology. Let's discuss and learn together. Join me in this quest for knowledge in cardiology.
…
continue reading
1
NEJM Interview: Elizabeth Tobin-Tyler on the contribution of violence against women to unwanted pregnancies and to injury and death during the peripartum period.
11:27
11:27
Play later
Play later
Lists
Like
Liked
11:27
Elizabeth Tobin-Tyler is an associate professor at the Brown University School of Public Health and Warren Alpert Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and S.L. Dickman. Rape, Homicide, and Abortion Bans — The Abandonment of People Subjected to Sexual and Intimate Partner…
…
continue reading
Featuring articles on treatments for metabolic dysfunction–associated steatohepatitis, blinatumomab in adults with ALL, and sotorasib for KRAS G12C–driven vascular malformations; a review article on HIV-associated tuberculosis; a case report of a woman with rapidly progressive dementia; and Perspectives on the abandonment of people subjected to sex…
…
continue reading
1
Love and Large Language Models: Voices of the Future with Dr. Rohaid Ali and Dr. Fatima Mirza
1:01:24
1:01:24
Play later
Play later
Lists
Like
Liked
1:01:24
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Rohaid Ali and Dr. Fatima Mirza, a married couple and chief residents at Brown University. The conversation explores their innovative work applying AI to health care, focusing on two major projects: Using ChatGPT to simplify surgical consent forms, making them mor…
…
continue reading
1
From Lab to Bedside: Former NEJM Editor Jeff Drazen on Making Research Clinically Relevant
31:05
31:05
Play later
Play later
Lists
Like
Liked
31:05
Thank you for your patience! After a short break, we are back with a delightful interview with Dr. Jeff Drazen, the esteemed former Editor-in-Chief of the New England Journal of Medicine (NEJM). In this episode, we explore the critical journey of transforming medical research into practical, patient-and-family centered care. We emphasize the import…
…
continue reading
Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […]SourceBy DrugPatentWatch
…
continue reading
A health care CEO’s most important responsibility is to maintain the sacredness of the patient-clinician relationship and ensure that interaction is as valuable for both the physician and the patient as possible.By Daniel E. Greenleaf, Thomas H. Lee
…
continue reading
Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […]SourceBy DrugPatentWatch
…
continue reading
To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […]SourceBy DrugPatentWatch
…
continue reading
The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […]SourceBy DrugPatentWatch
…
continue reading
What competencies are needed in the boardroom to advance the mission of creating healthier communities? How do health care system governance boards make these changes?By Brian Gragnolati, Thomas H. Lee
…
continue reading
In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]SourceBy DrugPatentWatch
…
continue reading
In the high-stakes world of pharmaceutical innovation, drafting detailed drug patent claims is a critical process that can make or […]SourceBy DrugPatentWatch
…
continue reading
As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […]SourceBy DrugPatentWatch
…
continue reading
Previous Next Time Stamps 03:05 What is hospice care and its philosophy? 06:15 Who qualifies for hospice? 08:19 Who makes up the hospice interdisciplinary team? 17:25 Who pays for hospice? 21:34 What are the different levels of hospice care? 31:59 What are some limitation of the hospice Medicare benefit? Sponsor: Freed is an AI scribe that listens,…
…
continue reading
What is the philosophy of hospice? (3:04) Who qualifies for hospice (6:13) Who makes up the hospice team (8:17) Who pays for hospice (17:24) What are the different levels of care (21:31) What are some limitations of the hospice medicare benefit? (31:57) Behind the Scenes Youtube Interview: Hospice Music Therapy Show notes & Transcript Sponsor: Free…
…
continue reading
Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed […]SourceBy DrugPatentWatch
…
continue reading
1
The chasm between how doctors are taught to communicate and what they actually sound like
46:09
46:09
Play later
Play later
Lists
Like
Liked
46:09
There is an idealized version of physician-patient communication that is taught in medical schools, reinforced with acronyms like PEARLS, SPIKES, and LEARN, but what resemblance does it bear to how doctors actually sound in the exam room? Co-host Saul Weiner leads a research team that has audio recorded and analyzed thousands of medical encounters.…
…
continue reading
In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount. Biosimilar manufacturers face unique challenges, including navigating […]SourceBy DrugPatentWatch
…
continue reading
1
Building your Ultrasound Skills: Bigger, Better, Buchanan!
24:00
24:00
Play later
Play later
Lists
Like
Liked
24:00
Join Brian Buchanan, Associate Professor and ultrasound guru, for a dose of iconoclasm and provocation. Recorded at the Critical Care Canada Forum in Toronto, and following a 2024 JICS publication by Brindley et al.
…
continue reading
Introduction The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office […]SourceBy DrugPatentWatch
…
continue reading
1
MedPod Today: Administrative Harm; GOP-Backed Alternative to IVF? 'Zebra' Stories
12:33
12:33
Play later
Play later
Lists
Like
Liked
12:33
MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discuss administrative harm, why there is no alternative to IVF despite what some GOP lawmakers say, and some zebra tales. Episode produced and hosted by Rachael Robertson. Sound engineer…
…
continue reading
Transitioning to a new Contract Development and Manufacturing Organization (CDMO) can be a complex and challenging process. However, by following […]SourceBy DrugPatentWatch
…
continue reading
The High Stakes of Pharmaceutical Patent Litigation In the fiercely competitive pharmaceutical industry, patent disputes can make or break a […]SourceBy DrugPatentWatch
…
continue reading
1
NEJM Interview: Ida Sim on the translation of ethical principles into oversight of new forms of artificial intelligence.
14:24
14:24
Play later
Play later
Lists
Like
Liked
14:24
Ida Sim is a professor of medicine at the University of California, San Francisco, and codirector of the Joint Program in Computational Precision Health at UC Berkeley and UCSF. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I. Sim and C. Cassel. The Ethics of Relational AI — Expanding and Implementing the Belm…
…
continue reading
Featuring articles on tenecteplase for ischemic stroke within 4.5 to 24 hours after the stroke, risankizumab vs. ustekinumab for Crohn’s disease, nirmatrelvir–ritonavir as Covid-19 postexposure prophylaxis, and efanesoctocog alfa in children with hemophilia A; a review article on the management of insomnia; a case report of a woman with postpartum …
…
continue reading
Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […]SourceBy DrugPatentWatch
…
continue reading
Send us a Text Message (please include your email so we can respond!) Episode 43! In this episode come close to finishing our dedicated discussion of the CCR24 trials talking about transfusion targets in TBI (HEMOTION) and dapagliflozin in critical illness (DEFENDER)! HEMOTION: https://www.nejm.org/doi/full/10.1056/NEJMoa2404360 HEMOTION (pubmed): …
…
continue reading
The Strategic Advantage of Complex Drug Delivery Systems In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can […]SourceBy DrugPatentWatch
…
continue reading
An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential […]SourceBy DrugPatentWatch
…
continue reading
The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […]SourceBy DrugPatentWatch
…
continue reading
In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]SourceBy DrugPatentWatch
…
continue reading
1
NEJM Interview: Erin Fuse Brown on a vertical-consolidation trend that has given insurance companies increased control over the care-delivery system.
10:55
10:55
Play later
Play later
Lists
Like
Liked
10:55
Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. H. Rooke-Ley, S. Shah, and E.C. Fuse Brown. Medicare Advantage and Consolidation’s New …
…
continue reading
Featuring articles on semaglutide and chronic kidney disease in type 2 diabetes, felzartamab in kidney-transplant rejection, bulevirtide and peginterferon for chronic hepatitis D, and nirsevimab and hospitalization for RSV bronchiolitis; a review article on malnutrition in adults; a case report of an infant with vomiting and hypercalcemia; and Pers…
…
continue reading
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]SourceBy DrugPatentWatch
…
continue reading
The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […]SourceBy DrugPatentWatch
…
continue reading
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […]SourceBy DrugPatentWatch
…
continue reading
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […]SourceBy DrugPatentWatch
…
continue reading
The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze […]SourceBy DrugPatentWatch
…
continue reading
A checklist of leadership skills for building trust through transparency, actions, and consistency that apply to health care mergers as well as day-to-day health care leadership.By Tina M. Freese Decker, Thomas H. Lee
…
continue reading
China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […]SourceBy DrugPatentWatch
…
continue reading
1
NEJM Interview: Evan Mullen on academic institutions’ participation in public debate, including in response to the opinions of their faculty members.
9:35
9:35
Play later
Play later
Lists
Like
Liked
9:35
Evan Mullen is a resident in the Department of Medicine at Stanford University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Mullen, E.J. Topol, and A. Verghese. Academic Freedom in America — In Support of Institutional Voices. N Engl J Med 2024;391:1-3.
…
continue reading
Featuring articles on stress ulcer prophylaxis during invasive mechanical ventilation, new therapies for hereditary angioedema, tissue factor–directed therapy in cervical cancer, and normalization of C1 inhibitor in a patient with hereditary angioedema; a review article on acute abdomen in the modern era; a Clinical Problem-Solving article on aggre…
…
continue reading